Compare Quest Diagnostics Inc (DGX) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs United States Oil ETF — how do they compare? Quest Diagnostics Inc trades at $205.37 (market cap $22.80B), while United States Oil ETF trades at $121.18. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while United States Oil ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, United States Oil ETF nearer its low. Which is the better fit depends on your goals.
| DGX | USO | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | — |
52-Week High | $216.02 | $152.96 |
52-Week Low | $166.42 | $66.17 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
USO is experiencing strong bullish momentum with the stock up 8.36% to $117.79 amid escalating Middle East tensions that have driven oil prices to one-month highs. Technical indicators show a bullish breakout pattern with strong support at $113 and resistance at $121, while RSI levels suggest potential overbought conditions. The fund has been the best-performing ETF of 2026 with gains exceeding 600%, benefiting from geopolitical risks in the Strait of Hormuz.
The outlook remains positive as renewed U.S.-Iran hostilities create sustained supply risks, though elevated RSI levels indicate potential near-term consolidation. Key risks include geopolitical de-escalation and demand concerns, while upside potential exists if tensions persist and drive oil prices toward $90 targets. Energy sector exposure provides portfolio diversification benefits during current market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
